Outcomes of systemic bivalirudin and sodium bicarbonate purge solution for Impella 5.5

Bivalirudin Versus Unfractionated Heparin in Patients with Cardiogenic Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation

(2022) Marissa N. Uricchio et al.   ASAIO JOURNAL

CARC12: Novel Purge System Modification Reduces Incidence of Impella 5.5 Dysfunction

(2022) Wyatt J. Klass et al.   ASAIO JOURNAL

Use of Tissue Plasminogen Activator Alteplase Purge Solution in an Impella 5.5 Heart Pump

(2021) Robert K. Tunney et al.   ASAIO JOURNAL

Incidence of Heparin-Induced Thrombocytopenia in Patients With Newly Implanted Mechanical Circulatory Support Devices

(2021) Long To et al.   ANNALS OF PHARMACOTHERAPY

A case series analysis on the clinical experience of Impella 5.5® at a large tertiary care centre

(2021) Peter J. Kennel et al.   ESC Heart Failure

Anticoagulation of Impella with a Bivalirudin Purge Solution

(2020) Thomas W. Szymanski et al.   ASAIO JOURNAL

Ischemic Stroke and Intracranial Hemorrhages During Impella Cardiac Support

(2020) Catherine E. Hassett et al.   ASAIO JOURNAL

Anticoagulation Management for Impella Percutaneous Ventricular Assist Devices: An Analysis of a Single-Center Experience

(2020) Ethan Wood et al.   ANNALS OF PHARMACOTHERAPY

Argatroban as Purge Solution in Patients With Heparin-Induced Thrombocytopenia on an Impella Device, a Case Review

(2020) Tanveer Mir et al.   AMERICAN JOURNAL OF THERAPEUTICS

Anticoagulation with temporary Impella device in patients with heparin-induced thrombocytopenia: A case series

(2020) Benjamin Hohlfelder et al.   INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS

Survey of Anticoagulation Practices with the Impella Percutaneous Ventricular Assist Device at High-Volume Centers

(2019) Brent N. Reed et al.   JOURNAL OF INTERVENTIONAL CARDIOLOGY

Utilization and Outcomes of Temporary Mechanical Circulatory Support Devices in Cardiogenic Shock

(2019) Tariq Enezate et al.   AMERICAN JOURNAL OF CARDIOLOGY

Use of Tissue Plasminogen Activator Alteplase for Suspected Impella Thrombosis

(2019) Luma Succar et al.   PHARMACOTHERAPY

Percutaneous Left-Ventricular Support With the Impella-2.5–Assist Device in Acute Cardiogenic Shock

(2012) Alexander Lauten et al.   Circulation-Heart Failure